Atazanavir Is a Competitive Inhibitor of SARS-CoV-2 Mpro, Impairing Variants Replication In Vitro and In Vivo.
Pharmaceuticals (Basel)
; 15(1)2021 Dec 24.
Article
in En
| MEDLINE
| ID: mdl-35056078
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Pharmaceuticals (Basel)
Year:
2021
Document type:
Article
Affiliation country: